APA (7th ed.) Citation

Hamakawa, M., Tanaka, A., Tokioka, F., & Ishida, T. (2024). Feasibility of continued treatment with dupilumab in patients with type 2 inflammatory disease who developed eosinophilic pneumonia: 3 case reports. Respirology Case Reports, 12(6), 1. https://doi.org/10.1002/rcr2.1412

Chicago Style (17th ed.) Citation

Hamakawa, Masamitsu, Ayaka Tanaka, Fumiaki Tokioka, and Tadashi Ishida. "Feasibility of Continued Treatment with Dupilumab in Patients with Type 2 Inflammatory Disease Who Developed Eosinophilic Pneumonia: 3 Case Reports." Respirology Case Reports 12, no. 6 (2024): 1. https://doi.org/10.1002/rcr2.1412.

MLA (9th ed.) Citation

Hamakawa, Masamitsu, et al. "Feasibility of Continued Treatment with Dupilumab in Patients with Type 2 Inflammatory Disease Who Developed Eosinophilic Pneumonia: 3 Case Reports." Respirology Case Reports, vol. 12, no. 6, 2024, p. 1, https://doi.org/10.1002/rcr2.1412.